Michael Berman
CIK 1186801 · last filed 2026-09-23
Michael Berman is a corporate insider who has filed 27 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for NSPR, was dated Sep 23, 2026. Across all open-market trades the lifetime net is +$310.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $268.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NSPR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUNNYVALE, CA 94085
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NSPR | Director | 597,580 | $0.45 | $268.9K | $260.0K | 21 | 2026-09-23 |
| InspireMD, Inc. (NSPRZ) Delisted | Director | 33,336 | $0.01 | $300 | $0 | 1 | 2021-11-12 |
| InspireMD, Inc. (NSPR.WS.B) Delisted | Director | 241,275 | $0.03 | $7.2K | $50.0K | 3 | 2021-02-10 |
| InspireMD, Inc. (NSPR.WS) Delisted | Director | — | $0.05 | — | $0 | 1 | 2016-12-08 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-23 | NSPR | Other (J) | — | $0 | EDGAR |
| 2026-01-16 | NSPR | Grant (A) | +88,053 | $0 | EDGAR |
| 2025-07-23 | NSPR | Exer (X) | +61,248 | $84.7K | EDGAR |
| 2025-01-10 | NSPR | Grant (A) | +32,491 | $0 | EDGAR |
| 2024-06-26 | NSPR | Exer (X) | +61,249 | $84.7K | EDGAR |
| 2024-01-25 | NSPR | Grant (A) | +29,032 | $0 | EDGAR |
| 2024-01-11 | NSPR | Grant (A) | +3,782 | $0 | EDGAR |
| 2023-10-04 | NSPR | Grant (A) | +3,106 | $0 | EDGAR |
| 2023-07-05 | NSPR | Grant (A) | +4,351 | $0 | EDGAR |
| 2023-05-19 | NSPR | Grant (A) | +149,260 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.